Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ARBUTUS BIOPHARMA CORP (ABUS)

182 + Investors. Track Smart Money conviction in ABUS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +4
Streak
2Q ▲
Buyers last Q
57%

Smart Money Signals — ABUS

Based on 168 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added ABUS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
168 hedge funds hold ABUS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +14% more funds vs a year ago

fund count last 6Q
+21 new funds entered over the past year (+14% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 57% buying

81 buying62 selling
Last quarter: 81 funds bought or added vs 62 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~23 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 29 → 14 → 23 → 23. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

50% of holders stayed for 2+ years

■ 50% conviction (2yr+) ■ 35% medium ■ 15% new
84 out of 168 hedge funds have held ABUS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~23 new funds/quarter

20 → 29 → 14 → 23 → 23 new funds/Q
New funds entering each quarter: 29 → 14 → 23 → 23. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 58% of holders stayed 2+ years

■ 58% veterans ■ 18% 1-2yr ■ 25% new
Of 182 current holders: 105 (58%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds
29 of 168 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in ABUS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ABUS

In 2025 Q4, 81 hedge funds were net buyers of ABUS (23 opened a new position, 58 added to an existing one), while 62 reduced or exited (43 trimmed, 19 sold completely) — a 57% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 44% of total institutional value in ABUS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +4 funds (more new holders than closures). Total institutional holders: 168.

Hedge Fund Ownership: ABUS

How many hedge funds hold ABUS — quarterly history vs. share price
Quarterly hedge fund ownership of ABUS vs. share price

Market Analysis: ABUS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ABUS

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

35 top-rated funds 2 high-conviction
Consensus
6.8
/ 10
breadth
×
Elite
3.1
/ 10
conviction
Hedge Fund Positioning: ABUS
2026 Q1 Stats Unlock in 6 days 182 + Investors

Track Smart Money conviction in ABUS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 182 177 2.82%
13F Shares 125M 121M 3.45%
Total Value $602M $549M 9.71%
New Positions 26 25 +1
Increased Positions 75 73 +2
Closed Positions 20 16 +4
Reduced Positions 55 65 -10
Total Calls 11 12 -8.33%
Total Puts 7 5 40.0%
PUT/CALL Ratio 0.64 0.42 Bullish

Statistics: ABUS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

182 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ABUS. Verified SEC 13F-HR filings.

Top 25 institutional holders of ABUS — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Western Standard LLC 1.23% 521,587 $2.3M
2 Ledgewood Wealth Advisors, LLC 0.71% 278,436 $1.3M
3 Wealth Management Associates, Inc. 0.20% 131,870 $593K
4 Carrera Capital Advisors 0.17% 252,159 $1.1M
5 Avidity Partners Management LP 0.12% 125,000 $525K
6 Freestone Capital Holdings, LLC 0.06% 442,500 $2.0M
7 Jefferies Financial Group Inc. 0.06% 1,894,067 $8.5M
8 JBF Capital, Inc. 0.05% 80,281 $361K
9 KENNEDY CAPITAL MANAGEMENT LLC 0.04% 393,132 $1.8M
10 CURA WEALTH ADVISORS, LLC 0.03% 15,000 $68K
11 WMG Financial Advisors, LLC 0.02% 12,605 $57K
12 Premier Path Wealth Partners, LLC 0.02% 40,000 $180K
13 Abel Hall, LLC 0.02% 20,073 $90K
14 China Universal Asset Management Co., Ltd. 0.01% 34,129 $154K
15 PROFUND ADVISORS LLC 0.01% 56,257 $253K
16 Clear Harbor Asset Management, LLC 0.01% 27,000 $122K
17 Hudson Bay Capital Management LP 0.01% 350,000 $1.6M
18 DRW Securities, LLC 0.00% 69,089 $311K
19 SBI Securities Co., Ltd. 0.00% 22,666 $102K
20 Magnetar Financial LLC 0.00% 58,516 $263K
21 Legal & General Group Plc 0.00% 2,401,389 $10.8M
22 PFG Investments, LLC 0.00% 11,000 $50K
23 E Fund Management Co., Ltd. 0.00% 15,443 $69K
24 Ameritas Investment Partners, Inc. 0.00% 12,648 $57K
25 CITIGROUP INC 0.00% 898,421 $4.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ARBUTUS BIOPHARMA CORP (ABUS)

What does the Smart Money Trend signal show for ABUS?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added ABUS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ABUS?

Slight buying edge — 57% buying: Last quarter: 81 funds bought or added vs 62 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ABUS holders?

Elite ownership — 44% AUM from top-100 funds: 29 of 168 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in ABUS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ABUS?

50% of holders stayed for 2+ years: 84 out of 168 hedge funds have held ABUS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.